KBC Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $243M | Buy |
4,009,205
+42,084
| +1% | +$2.45M | 0.61% | 21 |
|
|
2025
Q4 | $214M | Sell |
3,967,121
-102,790
| -3% | -$4.94M | 0.49% | 34 |
|
|
2025
Q3 | $184M | Buy |
4,069,911
+50,342
| +1% | +$2.35M | 0.44% | 38 |
|
|
2025
Q2 | $186M | Buy |
4,019,569
+169,974
| +4% | +$8.34M | 0.5% | 34 |
|
|
2025
Q1 | $235M | Sell |
3,849,595
-205,273
| -5% | -$12M | 0.73% | 19 |
|
|
2024
Q4 | $229M | Buy |
4,054,868
+628,908
| +18% | +$35.1M | 0.63% | 22 |
|
|
2024
Q3 | $177M | Sell |
3,425,960
-2,190,367
| -39% | -$103M | 0.54% | 30 |
|
|
2024
Q2 | $233M | Buy |
5,616,327
+320,737
| +6% | +$14.4M | 0.7% | 21 |
|
|
2024
Q1 | $287M | Buy |
5,295,590
+2,448,190
| +86% | +$125M | 0.91% | 17 |
|
|
2023
Q4 | $146M | Buy |
2,847,400
+1,367,151
| +92% | +$71.8M | 0.52% | 39 |
|
|
2023
Q3 | $85.9M | Sell |
1,480,249
-676,743
| -31% | -$41.5M | 0.35% | 65 |
|
|
2023
Q2 | $138M | Buy |
2,156,992
+656,724
| +44% | +$44M | 0.57% | 38 |
|
|
2023
Q1 | $104M | Sell |
1,500,268
-293,580
| -16% | -$20.7M | 0.44% | 48 |
|
|
2022
Q4 | $129M | Sell |
1,793,848
-1,032,048
| -37% | -$77.8M | 0.63% | 32 |
|
|
2022
Q3 | $201M | Sell |
2,825,896
-275,230
| -9% | -$20M | 1.04% | 12 |
|
|
2022
Q2 | $239M | Buy |
3,101,126
+79,629
| +3% | +$6.06M | 1.19% | 11 |
|
|
2022
Q1 | $221M | Buy |
3,021,497
+272,853
| +10% | +$18.3M | 0.87% | 15 |
|
|
2021
Q4 | $171M | Buy |
2,748,644
+32,810
| +1% | +$1.92M | 0.57% | 38 |
|
|
2021
Q3 | $161M | Sell |
2,715,834
-2,373,872
| -47% | -$156M | 0.59% | 33 |
|
|
2021
Q2 | $340M | Buy |
5,089,706
+492,098
| +11% | +$32.1M | 0.61% | 30 |
|
|
2021
Q1 | $290M | Buy |
4,597,608
+217,818
| +5% | +$13.6M | 0.59% | 37 |
|
|
2020
Q4 | $1.47B | Buy |
4,379,790
+968,886
| +28% | +$59.6M | 0.63% | 28 |
|
|
2020
Q3 | $206M | Buy |
3,410,904
+353,136
| +12% | +$21.3M | 0.61% | 32 |
|
|
2020
Q2 | $180M | Buy |
3,057,768
+2,214,745
| +263% | +$132M | 0.6% | 32 |
|
|
2020
Q1 | $47M | Sell |
843,023
-100,257
| -11% | -$6.13M | 0.39% | 55 |
|
|
2019
Q4 | $60.5M | Buy |
943,280
+69,199
| +8% | +$3.96M | 0.38% | 50 |
|
|
2019
Q3 | $44.3M | Buy |
874,081
+26,347
| +3% | +$1.24M | 0.33% | 59 |
|
|
2019
Q2 | $38.4M | Buy |
847,734
+108,964
| +15% | +$5.08M | 0.3% | 75 |
|
|
2019
Q1 | $35.2M | Buy |
738,770
+320,896
| +77% | +$16M | 0.29% | 79 |
|
|
2018
Q4 | $21.7M | Buy |
417,874
+15,465
| +4% | +$831K | 0.24% | 102 |
|
|
2018
Q3 | $25M | Buy |
402,409
+40,566
| +11% | +$2.41M | 0.19% | 140 |
|
|
2018
Q2 | $20M | Sell |
361,843
-11,408
| -3% | -$616K | 0.17% | 163 |
|
|
2018
Q1 | $23.6M | Buy |
373,251
+51,770
| +16% | +$3.33M | 0.22% | 117 |
|
|
2017
Q4 | $19.7M | Sell |
321,481
-151,287
| -32% | -$9.46M | 0.17% | 158 |
|
|
2017
Q3 | $30.1M | Buy |
472,768
+51,583
| +12% | +$3.01M | 0.27% | 92 |
|
|
2017
Q2 | $23.5M | Sell |
421,185
-441,854
| -51% | -$24M | 0.23% | 112 |
|
|
2017
Q1 | $46.9M | Buy |
863,039
+539,164
| +166% | +$29.6M | 0.42% | 53 |
|
|
2016
Q4 | $18.9M | Sell |
323,875
-24,830
| -7% | -$1.36M | 0.19% | 131 |
|
|
2016
Q3 | $18.8M | Sell |
348,705
-173,681
| -33% | -$11.2M | 0.22% | 108 |
|
|
2016
Q2 | $38.4M | Buy |
522,386
+134,184
| +35% | +$9.48M | 0.55% | 30 |
|
|
2016
Q1 | $24.8M | Buy |
388,202
+33,045
| +9% | +$2.08M | 0.41% | 53 |
|
|
2015
Q4 | $24.4M | Sell |
355,157
-47,977
| -12% | -$3.17M | 0.45% | 44 |
|
|
2015
Q3 | $23.9M | Sell |
403,134
-77,427
| -16% | -$4.91M | 0.48% | 40 |
|
|
2015
Q2 | $32M | Buy |
480,561
+43,929
| +10% | +$2.89M | 0.41% | 51 |
|
|
2015
Q1 | $28.2M | Sell |
436,632
-140,535
| -24% | -$8.8M | 0.36% | 71 |
|
|
2014
Q4 | $34.1M | Buy |
577,167
+417,813
| +262% | +$23.6M | 0.41% | 57 |
|
|
2014
Q3 | $8.16M | Sell |
159,354
-380,681
| -70% | -$19M | 0.28% | 90 |
|
|
2014
Q2 | $26.2M | Sell |
540,035
-197,902
| -27% | -$9.75M | 0.3% | 64 |
|
|
2014
Q1 | $38.3M | Buy |
737,937
+55,279
| +8% | +$2.94M | 0.61% | 29 |
|
|
2013
Q4 | $36.3M | Sell |
682,658
-97,457
| -12% | -$4.96M | 0.55% | 31 |
|
|
2013
Q3 | $36.1M | Buy |
780,115
+259,717
| +50% | +$11.4M | 0.58% | 28 |
|
|
2013
Q2 | $23.3M | Buy |
+520,398
| New | +$22.6M | 0.43% | 47 |
|
Other funds holding BMY
VCM
VPM
KBC Group's BMY Position: Q1 2026 in Review
KBC Group increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2026, buying an estimated $2.45M and bringing the position to 4,009,205 shares worth $243M. The position accounts for 0.61% of the portfolio, ranked #21.
KBC Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.47B in Q4 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- KBC Group held 4,009,205 shares of Bristol-Myers Squibb worth $243M as of Q1 2026.
- KBC Group bought 42,084 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.45M.
- Bristol-Myers Squibb made up 0.61% of KBC Group's portfolio in Q1 2026, its #21 holding.
- KBC Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Bristol-Myers Squibb position peaked at $1.47B in Q4 2020.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.